Is portal hypertension a contraindication to hepatic resection?

Annals of Surgery

Volumn 250, Issue 6, 2009, Pages 922-928

  Cucchetti, Alessandro ^a   Ercolani, Giorgio ^a   Vivarelli, Marco ^a   Cescon, Matteo ^a   Ravaioli, Matteo ^a   Ramacciato, Giovanni ^b   Grazi, Gian Luca ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PORTAL HYPERTENSION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; DECISION MAKING; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; HYPERTENSION, PORTAL; ITALY; LENGTH OF STAY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORBIDITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 73449104233     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b977a5     Document Type: Article

References (34)

1. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-823.
2. Thompson CJ, Rogers G, Hewson P, et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess. 2007;11:1-206.
3. Sherman M. Screening for hepatocellular carcinoma. Hepatol Res. 2007; 37(suppl 2):S152-S165.
4. Trevisani F, De Notaris S, Rapaccini G, et al; Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97:734-744.
5. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362:1907-1917.
6. Llovet JM, Bruix J, Gores G. Surgical resection versus transplantation for early hepatocellular carcinoma: clues for best strategy. Hepatology. 2000;31: 1019-1021.
7. Bruix J, Sherman M, Llovet JM, et al; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma: conclusions of the Barce-lona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430.
8. Bruix J, Sherman M. Management of hepatocellular carcinoma. AASLD practice guideline. Hepatology. 2005;42:1208-1235.
9. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-1022.
10. Capussotti L, Ferrero A, Viganò L, et al. Portal hypertension: contraindication to liver surgery? World J Surg. 2006;30:992-999.
11. Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatecto-mies without mortality in 8 years. Arch Surg. 2003;138:1198-1206.
12. Zaman A, Becker T, Lapidus J, et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;161:2564-2570.
13. Zinsmeister AR, Connor JT. Ten common statistical errors and how to avoid them. Am J Gastroenterol. 2008;103:262-266.
14. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234:71-78.
15. Cucchetti A, Siniscalchi A, Ercolani G, et al. Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma. Ann Surg. 2007;245:902-908.
16. Llovet JM, Brù C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-338.
17. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
18. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
19. Freeman RB, Wiesner RH, Harper A, et al; UNOS/OPTN Liver Disease Severity Score. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8:851-858.
20. Melendez JA, Arslan V, Fisher ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620-625.
21. Committee of the International Hepatopancreatobiliary Association. IHPBA Brisbane 2000 Terminology of Liver Anatomy and Resections. Vol 2. Abing-don, United Kingdom: Taylor & Francis; 2000:333-339.
22. Cucchetti A, Ercolani G, Vivarelli M, et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006;12:966-971. (Pubitemid 43960373)
23. Cucchetti A, Ercolani G, Cescon M, et al. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease. J Am Coll Surg. 2006;203:670-676. (Pubitemid 44648768)
24. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
25. Blackstone EH. Comparing apples and oranges. J Thorac Cardiovas Surg. 2002;123:8-15.
26. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
27. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265-2281.
28. Fan ST, Lo CM, Liu CL, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229:322-330.
29. Torzilli G, Makuuchi M, Inoue K, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg. 1999;134:984-992.
30. Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63-70.
31. Jaeck D, Bachellier P, Oussoultzoglou E, et al. Surgical resection of hepato-cellular carcinoma: post-operative outcome and long-term results in Europe; an overview. Liver Transpl. 2004;10(suppl 1):S58-S63.
32. Teh SH, Christein J, Donohue J, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. J Gastrointest Surg. 2005;9:1207-1215.
33. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobili-ary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708.
34. Ripoll C, Bañares R, Rincón D. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology. 2005;42:793-801.